I lead an amazing, passionate group of humans building technology that empowers other amazing, passionate humans to transform their companies into climate-focused organizations through resource exchange, reuse, and circularity. I have the absolute best job in the world, even on the bad days.

P33 is enabling Chicago to become a global Tech leader.

The Henry Crown Fellowship seeks to develop the next generation of community-spirited leaders, providing them with the tools to meet the challenges of the 21st century. It was established in 1997 to honor the life and career of Chicago industrialist Henry Crown (1896-1990) and was initially funded by the Henry and Gladys Crown Charitable Trust Fund. The program is the flagship Fellowship of the Aspen Institute and the founding Fellowship of the Aspen Global Leadership Network. For more information, visit http://www.aspeninstitute.org/crown.

Daniel Burnham Fellowship

Contributing to the ongoing Parkinson’s disease drug discovery efforts and helping Northwestern trainees, faculty, and staff more seamlessly connect to the Chicago business community.

Leading drug discovery effort in finding a selective Cav1.3 L-type calcium channel inhibitor for the treatment of Parkinson's disease.

EY-YourEncore alliance support and management.

As a member of the Life Science Practice - R&D division, I will help life science clients strive to find the right balance between protecting the business and driving measurable value.To help these clients drive value, I will be working with them to improve performance their supply chain and associated business activities.

My responsibilities included primary research recruitment and assessment, data synthesis and analysis, and market segmentation for biopharmaceutical clients interested in best pre-launch strategies for effective introduction of major life-changing/altering therapeutics.

Coordinated a drug discovery effort in finding a disease-modifying therapeutic for Parkinson's disease (PD). This novel approach for PD therapeutic development led to securing a US patent, several high profile peer-reviewed publications, several rounds of funding from federal agencies, non-profit organizations, and private investors. This results of this project have also been detailed in both local and national press. Most importantly, if this project is ultimately successful, the therapeutic products generated as a result will be of immense help to those currently suffering from PD.

Managed graduate teaching assistants, curriculum and a support staff of six for organic chemistry teaching laboratories, an essential course in the chemistry/biochemistry/pre-medicince degree tracks.